QUIA — QUIA PHARMA AB (publ) Income Statement
0.000.00%
Last trade - 00:00- SEK35.69m
- SEK35.68m
Annual income statement for QUIA PHARMA AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.86 | 0.216 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | -2.99 | 0.527 | 3.33 | 2.17 | 0.46 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 26.8 | 17.8 | 15.8 | 15.5 | 28.7 |
| Operating Profit | -24.9 | -17.6 | -15.8 | -15.5 | -28.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -27.7 | -20 | -20.1 | -16.5 | -28.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -27.7 | -20 | -20.1 | -16.5 | -28.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -27.7 | -20 | -20.1 | -16.5 | -28.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -27.7 | -20 | -20.1 | -16.5 | -28.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -34.9 | -12.8 | -4.55 | -2.73 | -0.025 |
| Dividends per Share |